Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine
Open Access
Abstract
Therapeutic vaccines based on dendritic cells offer a good approach to HIV-specific T-cell responses and partial control of the viral load after antiretroviral therapy interruption. The aim of the present study was to identify mRNA expression profiles and to assess the impact of the gut microbiome composition for predicting the viral load control after antiretroviral therapy interruption. We enrolled 29 patients to receive either placebo or a monocyte-derived dendritic cell vaccine. Patients with a decrease in their viral load of >0.5 log10 copies/mL by 12 weeks after antiretroviral therapy interruption were considered responders. In total, 66 genes were considered differentially expressed between responders and non-responders. Enrichment analysis revealed several upregulated pathways involved in the host defense response to a virus via the type I interferon signaling pathway. Regarding the gut microbiota, responders showed enriched levels of Bacteroidetes (p < 0.005) and Verrucomicrobia (p = 0.017), while non-responders were enriched with Tenericutes (p = 0.049) and Actinobacteria (p < 0.005). We also found important differences at the genus level. However, we did not discover any effect of the dendritic cell vaccine on the transcriptome or the gut microbiota. An alternative analysis did characterize that the microbiota from responders were associated with the metabolic production of short-chain fatty acids, which are key metabolites in the regulation of intestinal homeostasis. The evidence now consistently shows that short-chain fatty acid depletion occurs in HIV-infected individuals receiving antiretroviral treatment.Keywords
Funding Information
- SPANISH AIDS Research Network (RIS) projects (RD16/0025/0002 and RD16/0025/0013)
- European Regional Development Fund (AC16/00051, and PI18/00699)
- Spanish Ministry of Economy (MINECO) (SAF2015-66193-R, RTI2018-096309-B-I00)
This publication has 41 references indexed in Scilit:
- Diversity of Butyrivibrio Group Bacteria in the Rumen of Goats and Its Response to the Supplementation of Garlic OilAsian-Australasian Journal of Animal Sciences, 2014
- Differential Response of the Cynomolgus Macaque Gut Microbiota to Shigella InfectionPLOS ONE, 2013
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences, 2013
- Impact of Oral Typhoid Vaccination on the Human Gut Microbiota and Correlations with S. Typhi-Specific Immunological ResponsesPLOS ONE, 2013
- The Intestinal Flora Is Required to Support Antibody Responses to Systemic Immunization in Infant and Germ Free MicePLOS ONE, 2011
- KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseasesNucleic Acids Research, 2011
- A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 InfectionThe Journal of Infectious Diseases, 2011
- Should the Human Microbiome Be Considered When Developing Vaccines?PLOS Pathogens, 2010
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humansNature Immunology, 2008
- Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infectionProceedings of the National Academy of Sciences, 2003